🇺🇸 FDA

Company profile · Sponsor

Vera

Vera Therapeutics

VERA · NYSE pharma BRISBANE, CA, USA
Pipeline
20
Drugs
2
Patents
8

Quick answer

Vera (VERA) is a pharma company. headquartered in BRISBANE, CA, USA. listed on NYSE. NovaPharmaNews links 20 pipeline programs, 2 drugs, and 8 patents to this profile..

Company facts

Ticker VERA
Exchange NYSE
Company type pharma
Headquarters BRISBANE, CA, USA
SEC CIK 0001831828

Pipeline (20)

Search pipeline →

  1. Atacicept

    Vera

    IgA Nephropathy

    phase 3 mab active

    1 trial

  2. Atacicept

    Vera

    Lupus Nephritis (LN)

    phase 3 small molecule terminated

    1 trial

  3. Immune Globulin 10% Intravenous Solution

    Vera

    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    phase 3 small molecule active

    1 trial

  4. Topotecan HEXAL 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Paclitaxel AqVida 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Paclitaxel Ribosepharm 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Anastrozol STADA® 1 mg Filmtabletten, Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion, VS-6766, LETRO-cell® 2,5 mg Filmtabletten, VS-6063, Letrozol - 1 A Pharma® 2,5 mg Filmtabletten, ZOLSKETIL pegylated liposomal 2 mg/mL concentrate for dispersion for inf

    Vera

    Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

    phase 3 small molecule active

    1 trial

  5. Analogs, Prostaglandin E1

    Vera

    Covid19

    phase 2 small molecule terminated

    1 trial

  6. Atacicept

    Vera

    IgA Nephropathy (IgAN); Berger Disease; Renal and Urinary Disorders

    phase 2 small molecule active

    1 trial

  7. Atacicept

    Vera

    IgA Nephropathy (IgAN)

    phase 2 small molecule active

    1 trial

  8. Atacicept

    Vera

    pMN

    phase 2 small molecule active

    1 trial

  9. Atacicept 150 mg

    Vera

    IgA Nephropathy (IgAN)

    phase 2 small molecule active

    1 trial

  10. Atacicept Autoinjector Combination, Atacicept

    Vera

    Treatment of IgAN

    phase 2 small molecule active

    1 trial

  11. Atacicept Autoinjector Combination, Atacicept

    Vera

    Multiple Autoimmune Glomerular Diseases

    phase 2 small molecule active

    1 trial

  12. Capecitabine

    Vera

    Breast Cancer

    phase 2 small molecule terminated

    1 trial

  13. Genomically Directed Monotherapy

    Vera

    Malignant Neoplasm of Breast

    phase 2 small molecule completed

    1 trial

  14. MAU868

    Vera

    BK Virus Infection

    phase 2 small molecule completed

    1 trial

  15. NestaCell®

    Vera

    COVID-19 Pneumonia

    phase 2 mab completed

    1 trial

  16. VS-6766, VS-6063

    Vera

    Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

    phase 2 small molecule active

    1 trial

  17. riliprubart

    Vera

    Autoimmune haemolytic anaemia

    phase 1 small molecule active

    1 trial

  18. CYP2C19 genotyping

    Vera

    Myocardial Infarction

    approved gene therapy completed

    1 trial

  19. Experimental: Hyperslim

    Vera

    Venous Thromboembolism (VTE)

    approved other active

    1 trial

  20. Nitazoxanide Tablets

    Vera

    COVID-19

    small molecule completed

    1 trial

Drugs (2)

Search drugs →

  1. avutometinib potassium

    AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)

    ORAL approved

  2. verard

    VERARD

    UNKNOWN approved

Patents (8)

Search patents →

  1. US 12403164

    Lentiviral vector formulations

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12403183

    Factor VIII polypeptide formulations

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12391750

    Anti-C1S antibodies and methods of use thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12371747

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12364774

    Nucleic acid molecules and uses thereof for non-viral gene therapy

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12268688

    Compositions and methods of use for modified release minoxidil

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12257288

    Methods of inducing immune tolerance to clotting factors

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12240917

    Anti-complement C1s antibodies and uses thereof

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Vera?

Vera (VERA) is a pharma company. headquartered in BRISBANE, CA, USA. listed on NYSE. NovaPharmaNews links 20 pipeline programs, 2 drugs, and 8 patents to this profile..

What pipeline programs does Vera sponsor?

We track 20 ClinicalTrials.gov-linked programs for Vera, including Atacicept and 19 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Vera company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.